HomeMOB • STO
add
Moberg Pharma AB (publ)
Previous close
kr 8.32
Day range
kr 8.40 - kr 8.75
Year range
kr 6.34 - kr 39.78
Market cap
410.33M SEK
Avg Volume
105.24K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 3.87M | 371.83% |
Operating expense | 6.70M | -20.15% |
Net income | -2.77M | 57.36% |
Net profit margin | -71.59 | 90.96% |
Earnings per share | — | — |
EBITDA | -3.73M | 51.91% |
Effective tax rate | 13.11% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 268.90M | 596.06% |
Total assets | 702.87M | 11.21% |
Total liabilities | 17.40M | -35.99% |
Total equity | 685.48M | — |
Shares outstanding | 46.17M | — |
Price to book | 0.56 | — |
Return on assets | -1.47% | — |
Return on capital | -1.50% | — |
Cash Flow
Net change in cash
(SEK) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -2.77M | 57.36% |
Cash from operations | -8.72M | -130.03% |
Cash from investing | -15.28M | 14.24% |
Cash from financing | -391.00K | -25.32% |
Net change in cash | -24.39M | -11.27% |
Free cash flow | -24.86M | -30.33% |
About
Founded
2006
Website
Employees
9